The Hereditary Cancer Clinic is part of the Duke Comprehensive Cancer Center.

At the Duke Comprehensive Cancer Center, we are devoted to giving every patient we serve the best possible chance of recovery.

One of only 40 centers in the country designated by the National Cancer Institute (NCI) as a “comprehensive cancer center,” Duke combines cutting-edge research with compassionate care.

With more than $256 million in cancer research funding annually, Duke researchers have developed new therapies for cancer treatment that are now standards of care worldwide. At any given time, we offer patients access to over 400 clinical trials testing promising new treatments.

Our team of nationally recognized physicians and staff treat over 6,000 new patients per year, giving them the extensive experience that yields better results. In fact, U.S.News & World Report rates Duke among the best in the nation for cancer care -- and best in the Southeast.

We also provide an extensive array of education and support services to help patients and their families throughout the course of treatment and recovery.

Research

Clinic staff work closely with other researchers from Duke and cancer centers nationwide to better understand inherited cancers and to develop new tools for estimating cancer risk.

Through the Hereditary Cancer Clinic, individuals may be given the opportunity to be involved in research projects, including a study testing the cost-effectiveness of using videoconferencing to provide cancer genetic counseling to patients in rural North Carolina.